Saizen® has been treating growth hormone (GH) deficiency since 1996 and Saizen® devices are designed with the patient in mind.
Saizen® must be given by injection. The injection is subcutaneous, which means the medication is delivered into the fatty tissue that lies just below the skin. Saizen® can be administered via several delivery devices. Your doctor will help you choose the delivery device that’s right for you.
Saizen® delivery devices include:
easypod® — an electronic, automated drug delivery device
Saizen® is also available for use with standard needle and syringe in 5mg and 8.8mg vials.